A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, ...

A new therapy for the most aggressive type of brain cancer can extend patients' survival while cutting the length of ...

From this collected data, the researchers determined that tumors excised six or more years after discovery tended to be ...

The Shanghai Proton and Heavy Ion Center has emerged as a leading facility for cancer treatment. Better medical processes and ...

Researchers from POSTECH and Kyungpook National University have developed a novel inhalable therapeutic delivery system for ...

Shares of Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report) reached a new 52-week high during mid-day trading on Friday . The stock traded as high as C$3.50 and last traded at C$3.45, with a ...

The wound was disinfected and dressed with a bandage, but months later and the surgeon noticed something was seriously wrong ...

Tests found that the surgeon did not have any signs of immune deficiency and the tumor was successfully removed from his hand. When it was tested, it was found that the tumor was a malignant fibrous ...

Shares of Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report) have been given an average recommendation of “Buy” by the five analysts that are currently covering the company, MarketBeat.com ...

This is an important technical method paper that details the development and quality assessment of a 3D MERFISH method to enable spatial transcriptomics of thick tissues, representing a major step ...

gDepartment of Pathology and Stanford Center for Genomics and Personalized Medicine, Stanford University School of Medicine, Stanford, CA, USA, hStanford Cancer Institute, Stanford University School ...